Biotechnology Reagents - Global Strategic Business Report

The global market for Biotechnology Reagents was valued at US$104.3 Billion in 2024 and is projected to reach US$135.1 Billion by 2030, growing at a CAGR of 4.4% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Biotechnology Reagents - Key Trends and Drivers

Biotechnology reagents are critical in the realm of modern biotechnological research and applications, enabling a myriad of processes such as DNA cloning, sequencing, labeling, mutagenesis, and various polymerase chain reaction (PCR) methodologies. As central components in molecular biology, they support advanced genetic research, pharmacology, and diagnostics, with the development of new techniques necessitating an increased demand for specialized reagents and kits. This requirement is facilitating growth not only within established markets but also opening avenues in emerging fields where these reagents are integral to innovation and application expansion.

The global biotechnology reagents market is witnessing substantial growth fueled by significant investments in research and development from governments, academic institutions, and private sectors, particularly in areas such as stem cell research and synthetic biology. These investments are propelling advancements in CRISPR gene editing technology, next-generation sequencing (NGS), and personalized medicine, thereby increasing the need for high-quality reagents. The continuous expansion of biotechnological applications, coupled with the growing importance of diagnostics and biopharmaceuticals in healthcare, is boosting the demand for these specialized reagents.

Technological innovations within the sector are critical in driving the biotechnology reagents market forward, with developments in fluorescence-based assays, high-throughput screening technologies, and the production of biopharmaceuticals necessitating advanced reagents that offer higher sensitivity and specificity. The expansion of the diagnostics sector, spurred by the COVID-19 pandemic and the increasing prevalence of chronic diseases, further underscores the need for precise diagnostic reagents. Additionally, the growing trend of collaborations between academic and commercial entities to expedite the commercialization of research is enhancing the demand for sophisticated biotechnology reagents, supporting the dynamic growth of this market.

Report Scope

The report analyzes the Biotechnology Reagents market, presented in terms of market value (USD). The analysis covers the key segments and geographic regions outlined below.

Segments

Technology (Chromatography, In-vitro Diagnostics, PCR, Cell Culture, Other Technologies).

Geographic Regions/Countries

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Chromatography Technology segment, which is expected to reach US$40.6 Billion by 2030 with a CAGR of a 3.4%. The In-vitro Diagnostics Technology segment is also set to grow at 3.7% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, valued at $27.8 Billion in 2024, and China, forecasted to grow at an impressive 7.3% CAGR to reach $28.4 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Biotechnology Reagents Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Biotechnology Reagents Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Biotechnology Reagents Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of players such as Abbott Molecular, Inc., Agilent Technologies, Inc., BD Biosciences, bioMerieux SA, Bio-Rad Laboratories, Inc. and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 267 companies featured in this Biotechnology Reagents market report include:

• Abbott Molecular, Inc.
• Agilent Technologies, Inc.
• BD Biosciences
• bioMerieux SA
• Bio-Rad Laboratories, Inc.
• Bio-Techne Coporation
• Danaher Corporation
• F. Hoffmann-La Roche AG
• Fitzgerald Industries International
• General Electric Company
• Hoefer, Inc.
• Lonza Group Ltd.
• Merck KGaA
• Meridian Bioscience, Inc.
• Olympus Corporation
• Ortho Clinical Diagnostics
• PerkinElmer, Inc.
• Promega Corporation
• Quality Biological, Inc.
• Siemens Healthineers
• Sysmex Corporation
• Takara Holdings, Inc.
• Thermo Fisher Scientific, Inc.
• Tosoh Europe N.V.
• W. R. Grace & Co.
• Waters Corporation